The blockade of the reinforcing effects of angiotensin-II on hemodynamic parameters in rats with experimental diabetes mellitus

The blockade of the reinforcing effects of angiotensin-II on hemodynamic parameters in rats with experimental diabetes mellitus

Diabetes mellitus (DM) causes not only carbohydrate metabolism, but and disorders of the cardiovascular system, resulting in developing hypertension. It is known that in the regulation of hemodynamics the renin-angiotensin system plays an important role, the effector peptide of which is angiotensin...

Full description

Bibliographic Details
Main Authors:	O N Serova, E Yu Kalashnikova, A I Elfimov, L V Lagutina, V I Torshin
Format:	Article
Language:	English
Published:	Peoples’ Friendship University of Russia (RUDN University) 2015-12-01
Series:	RUDN Journal of Medicine
Subjects:	ангиотензин-II аутоиммунный сахарный диабет 1 типа систолическое артериальное давление частота сердечных сокращений
Online Access:	http://journals.rudn.ru/medicine/article/view/3148

Similar Items

Реакция артериального давления на реальные и воображаемые движения
by: Татьяна Ромульевна Мошонкина, et al.
Published: (2022-11-01)

Изменения оперативных индикаторных характеристик сердечно-сосудистой системы пожарных-спасателей, определяющих группу риска
by: Екатерина Дмитриевна Целых, et al.
Published: (2024-02-01)

Динамика показателей сердечно-сосудистой системы женщин с алиментарно-конституциональной формой ожирения I–II степени при синдроме поликистозных яичников под влиянием программы физической реабилитации
by: Ольга Скомороха
Published: (2016-10-01)

Characteristics of the circadian profile of heart rate during genetically determined hypertension
by: V A Goryachev, et al.
Published: (2014-12-01)

Daily rhythm of blood pressure at patients with autoimmune thyreoiditis depending on function of the thyroid gland
by: Ye. B. Kravets, et al.
Published: (2008-12-01)

Reversal of vascular hypertrophy in hypertensive patients through blockade of angiotensin II receptors
by: R. D. Smith, et al.
Published: (2010-12-01)

Heart rate reduction as a therapeutic goal: focus on primary prevention
by: Yu. A. Orlova, et al.
Published: (2012-02-01)

The role of cytokines in the pathogenesis of autoimmune diabetes, immune intervention issues
by: Ye. B. Kravets, et al.
Published: (2010-02-01)

Heart rate-reducing agents ivabradine and beta-adrenoblockers in the management of patients with stable effort angina
by: Z. M. Galeeva, et al.
Published: (2011-02-01)

ОБЪЕКТИВНАЯ ДИАГНОСТИКА ПРЫЖКОВОЙ РАБОТОСПОСОБНОСТИ ВОЛЕЙБОЛИСТОВ С ИСПОЛЬЗОВАНИЕМ СЕНСОРНО-КОМПЬЮТЕРНОЙ УСТАНОВКИ
by: Азад Артыкович Пулатов, et al.
Published: (2020-05-01)

«MEMORIES OF FUTURE»: CHANGE IN VERAPAMIL SIGNIFICANCE IN THE TREATMENT OF PATIENTS WITH ISCHEMIC HEART DISEASE AND ARTERIAL HYPERTENSION
by: S. R. Gilyarevskiy
Published: (2015-09-01)

INTERETHNIC ASSOCIATIONS OF INCREASED HEART RATE AS A FACTOR OF CARDIOVASCULAR RISK. PART 2: GENETIC MARKERS
by: T. A. Mulerova, et al.
Published: (2021-03-01)

Ivabradine – a new agent for coronary heart disease treatment
by: O. A. Maneshina, et al.
Published: (2006-06-01)

ВРЕМЕННЫЕ СООТНОШЕНИЯ ЭЛЕМЕНТОВ ЭКГ И ЧАСТОТЫ СЕРДЕЧНЫХ СОКРАЩЕНИЙ ЧЕЛОВЕКА В ПОКОЕ
by: Ekaterina Aleksandrovna Dudnikova, et al.
Published: (2016-05-01)

MATHEMATICAL MODEL OF DOUBLE-PHASE HOMEOSTASIS SYSTEM BY THE EXAMPLE OF SYSTOLIC BLOOD PRESSURE
by: Maria S. Gavrilova
Published: (2012-02-01)

INTERETHNIC ASSOCIATIONS OF INCREASED HEART RATE AS A FACTOR OF CARDIOVASCULAR RISK. PART 1: СLINICAL MARKERS
by: T. A. Mulerova, et al.
Published: (2020-12-01)

ИЗМЕНЕНИЕ ПОКАЗАТЕЛЕЙ СЕРДЕЧНОГО РИТМА И КАРДИОИНТЕРВАЛОВ У ДЕТЕЙ 6-7 ЛЕТ В ОТВЕТ НА АКТИВНУЮ ОРТОСТАТИЧЕСКУЮ ПРОБУ
by: Nadezhda Gennadyevna Russkih, et al.
Published: (2016-05-01)

Effects of the fixed-dose combination therapy with indapamide and valsartan on renal function in patients with Type 2 diabetes mellitus and arterial hypertension
by: T. V. Malykh, et al.
Published: (2011-12-01)

HIGH HEART RATE AS A POTENTIAL RISK FACTOR FOR DEVELOPMENT OF CARDIOVASCULAR DISEASES IN WOMEN WITH RHEUMATOID ARTHRITIS
by: D. S. Novikova, et al.
Published: (2015-12-01)

CHALLENGING PROBLEMS OF HYPERTENSION MANAGEMENT: THE EFFECT OF INCREASED HEART RATE AND COMORBIDITIES ON THE CHOICE OF ANTIHYPERTENSIVE THERAPY IN PRACTICE OF CARDIOLOGIST AND THERAPIST. The Conclusion of the Expert Council
by: G. P. Arutyunov, et al.
Published: (2015-09-01)

Risk of fatal and non-fatal cardiovascular events in men aged 25-44 in the city of Novosibirsk. Cohort study
by: E. V. Stryukova, et al.
Published: (2023-02-01)

Pace-maker f-channels of sinus node myocytеs as a new therapeutic target for heart rate reduction
by: E. I. Astashkin, et al.
Published: (1970-01-01)

ПОКАЗАТЕЛИ ПУЛЬСА, ЦЕНТРАЛЬНОГО И ПЕРИФЕРИЧЕСКОГО АРТЕРИАЛЬНОГО ДАВЛЕНИЯ У ПЕДАГОГОВ СЕВЕРНОГО УНИВЕРСИТЕТА, ПЕРЕНЕСШИХ COVID-19 В ПЕРИОД ДИСТАНЦИОННОЙ РАБОТЫ
by: Marina A. Popova, et al.
Published: (2021-08-01)

Autoimmunnyy poliglandulyarnyy sindrom III tipa (DTZ, sakharnyy diabet I tipa, autoimmunnyy glomerulonefrit)
by: K I Tabeeva, et al.
Published: (2004-12-01)

Modern aspects of angina treatment in arterial hypertension patients: emphasizing endothelial function role
by: L. L. Kirichenko, et al.
Published: (2008-04-01)

Pharmacological effects оп sympathetic tonus and heart rate in cardiovascular disease
by: N. Sh. Zagidullin, et al.
Published: (2009-04-01)

NEURO ENGINEERING TECHNOLOGY TO ACCELERATE THE HUMAN ADAPTATION TO HIGH ALTITUDE HYPOXIA
by: Mukhamed T. Shaov, et al.
Published: (2018-03-01)

EFFECT OF THE COMBINED ANTIHYPERTENSIVE THERAPY WITH TARGET BLOOD PRESSURE ACHIEVEMENT ON INTRARENAL BLOOD FLOW IN PATIENTS WITH TYPE 2 DIABETES
by: O. A. Koshel'skaya, et al.
Published: (2015-12-01)

Kontraieptsiya u zhenshchin, bol'nykh sakharnym diabetom 1 i 2 tipa
by: E E Grodnitskaya, et al.
Published: (2003-06-01)

Development of an Algorithm for Clustering Cardiac ECG Signals with Post-Correction for Long-Term ECG Monitoring
by: I. A. Kondratyeva, et al.
Published: (2021-04-01)

THE CLINICAL SIGNIFICANCE OF THE DAILY MONITORING OF HOLTER ECG IN CHRONIC GLOMERULONEPHRITIS AT THE PREDIALYSIS STAGE OF THE DISEASE
by: I. T. Murkamilov, et al.
Published: (2019-02-01)

Hyperbaric oxygenation in complex treatment of pregnant women with diabetes mellitus type I
by: T V Kuzenkova, et al.
Published: (2011-12-01)

Sakharnyy diabet i endotelial'naya disfunktsiya
by: Ivona Renata Yarek-Martynova, et al.
Published: (2004-06-01)

EFFICACY OF AZILSARTAN MEDOXOMIL ON THE DAILY PROFILE OF PERIPHERAL AND CENTRAL ARTERIAL PRESSURE AND ARTERIAL STIFFNESS IN HYPERTENSIVES WITH TYPE 2 DIABETES
by: E. A. Troitskaya, et al.
Published: (2017-02-01)

New approach to heart rate control as mortality reduction method in cardiac patients: potential of a new If inhibitor, ivabradine
by: Yu. B. Belousov, et al.
Published: (2007-12-01)

Positive effect of if-channel’s blocker ivabradine therapy in a patient with ischemic chronic heart failure with preserved left ventricle ejection fraction and hereditary thrombophilia (clinical case)
by: Iurii N. Belenkov, et al.
Published: (2019-09-01)

Glibomet v lechenii sakharnogo diabeta 2 tipa
by: Alexander Sergeevich Ametov, et al.
Published: (2007-06-01)

Prediktory angiopatiy u patsientov s narushennoy tolerantnost'yu k glyukoze i vpervye vyyavlennym sakharnym diabetom 2 tipa
by: I A Romanenko, et al.
Published: (2005-06-01)

Hemodynamic changes in different types of carotid endarterectomy in the short- and long-term postoperative periods in patients with carotid artery stenosis
by: P. V. Ignatenko, et al.
Published: (2020-11-01)

Clinical and hormonal status of boys-teenagers with type 1 diabetes
by: Ye. A. Solodilova, et al.
Published: (2011-08-01)